Stem Cell Content

��ϲ��Ͽ� Davis Engineers Lead $36M Effort to Improve Recovery From Spinal Cord Injuries

Andy Fell — September 30, 2020 - 9:00am

Engineers at the University of California, Davis, will lead a consortium of universities, biomedical startups and nonprofit organizations to develop interventions for spinal cord injuries that can be applied within days of injury to improve long-term outcomes.

��ϲ��Ͽ� Davis Invests $4 Million to Launch New Research Centers

Andy Fell — September 12, 2019 - 3:54pm

The University of California, Davis, is investing $4 million over three years to launch four new research centers that align campus strengths with unique opportunities for global impact. The ��ϲ��Ͽ� Davis Office of Research initiative is designed to promote new, sustainable, inter- and multidisciplinary research activity that responds to society’s greatest challenges and needs.

Stem Cell Treatment for Children With Spina Bifida Helps Dogs First

Katherine E Kerlin — August 24, 2017 - 11:01am

A pair of English bulldog puppies are the first patients to be successfully treated with a unique therapy — a combination of surgery and stem cells — developed at the University of California, Davis, to help preserve lower-limb function in children with spina bifida.

(Editor’s note: Photos and b-roll available.)

Neural Stem Cells Steered by Electric Fields in Rat Brain

Andy Fell — July 11, 2017 - 3:24pm

Electric fields can be used to guide neural stem cells transplanted into the brain toward a specific location. The research, published July 11 in the journal Stem Cell Reports, opens possibilities for effectively guiding stem cells to repair brain damage.

Cat Stem Cell Therapy Gives Humans Hope

Patricia Bailey — February 01, 2016 - 3:56pm

By the time Bob the cat came to the ��ϲ��Ͽ� Davis veterinary hospital, he had used up most of his nine lives. Afflicted with a painful oral inflammatory disorder, Bob had already lost all of his teeth in an effort to treat the disease known as feline chronic gingivostomatitis, or FCGS. In a last-ditch effort, Bob’s owner enrolled him in a clinical trial to receive a novel stem cell therapy treatment.